Clinical Trial Update: Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing meropenem to piperacillin-tazobactam in bloodstream infection, assessing mortality and clinical response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infections

Drugs mentioned

• Meropenem (Meropenem)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: The University of Queensland | Conditions: Bloodstream Infections | Phase 4 | Status: COMPLETED